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AbsTrACT
background Locally relevant research is considered critical 
for advancing health and development in low- and middle-
income countries (LMICs). Accordingly, health research 
capacity strengthening (HRCS) efforts have intensified, 
increasingly through consortia. Yet, the knowledge base for 
managing such consortia is not well defined. This review 
aimed to ascertain the scope and quality of published 
literature on HRCS consortium management processes, 
management-related factors influencing consortium 
operations and outcomes, and the knowledge gaps.
Methods Given the paucity of published HRCS literature, a 
‘systematised review’ as outlined by Grant and Booth was 
conducted, modelling the systematic review process without 
restriction to research-based publications. A systematic 
search in PubMed and Scopus was carried out coupled with 
a manual search for papers using reference checking and 
citation searching. A quality appraisal of eligible articles using 
the Mixed Method Appraisal Tool was undertaken. Thematic 
synthesis was used to analyse the extracted data.
results The search identified 55 papers, made up of 
18 empirical papers and 37 commentaries focusing on 
consortium-based HRCS initiatives involving LMICs and 
reporting management-related data. The review indicates 
increasing efforts being made in the HRCS field in reporting 
consortia outcomes. However, it highlights the dearth of high-
quality empirical research on HRCS consortium management 
and the nascent nature of the field with most papers 
published after 2010. The available literature highlights the 
importance of relational management factors such as equity 
and power relations in influencing consortium success, 
though these factors were not explored in depth. Operational 
management processes and their role in the capacity 
strengthening pathway were rarely examined.
Conclusion Findings indicate a weak evidence base for 
HRCS consortium management both in terms of quantity and 
conceptual depth, demonstrating the need for an expanded 
research effort to inform HRCS practice.
InTroduCTIon
Health research has been recognised as an 
essential tool in addressing health and devel-
opment challenges, yet the capacity of many 
low- and middle-income countries (LMICs) 
to conduct locally relevant research is still 
low.1 2 In the last three decades, several calls to 
action have been made for sustainable health 
research capacity strengthening (HRCS) in 
LMICs,1–4 resulting in substantial investments 
in a wide range of initiatives.5–7 Mechanisms for 
developing research capacity in LMICs have 
evolved over the years, progressing from the 
provision of technical assistance to individu-
al-focused training, and more recently towards 
institutional and system-wide approaches.8 9 
One of the main strategies adopted over the 
period has been the teaming up of institutions 
to implement these programmes.6 10 Though 
such groupings refer to themselves by various 
names such as partnership, consortium, and 
network,11–13 we will use the term ‘consortium’ 
in this paper.
HRCS consortia typically consist of individuals 
and institutions from both high- and low- and 
Key questions
What is already known?
 ► The recognition of the fundamental role of research 
in advancing health and development has resulted in 
substantial investments in health research capacity 
strengthening (HRCS) consortia in low- and mid-
dle-income country settings.
What are the new findings?
 ► Very little attention has been given to consortium 
management in the literature, and the current evi-
dence is characterised by a lack of high-quality em-
pirical research.
 ► The available evidence highlights the importance of 
relational elements of consortium management such 
as equity and power relations but does not explore 
these elements in depth. Operational management 
processes adopted and their role in the capacity 
strengthening pathway were rarely examined.
What do the new findings imply?
 ► There is a need to strengthen the evidence base on 
the role and contribution of consortium management 
processes to broader HRCS capacity development 
initiatives.
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middle-income countries pooling their varying levels of 
resources, expertise and experience and working together 
towards collective gains in health research capacity.14 15 
While these consortia are often led by high-income country 
partners,16 17 there is a rising trend of LMIC-led consortia 
such as those that were supported by the Wellcome Trust’s 
African Institutions Initiative and its successor, the Devel-
oping Excellence in Leadership, Training and Science 
Africa Initiative, the USA National Institute of Health’s 
Medical Education Partnership Initiative, and the Euro-
pean and Developing Countries Clinical Trials Partnership 
Programmes.
The increase in HRCS consortia has heightened the 
need to assess their activities and effectiveness. Accounts 
of HRCS consortia in the literature have generally focused 
on programme activities and outputs and associated 
successes and challenges.18–20 However, current evalua-
tion thinking embraces the value of processes in addition 
to outcomes,21 22 recognising that assessing programme 
implementation processes to determine how and why 
specific outputs are realised is as important as assessing 
the outputs themselves.22 23 Integral to programme imple-
mentation processes are the management structures and 
activities employed throughout its lifecycle.24 Managing 
a consortium is often a complex effort involving coor-
dination of both activities and partners (individual and 
institutional) that are, in turn, embedded in additional 
structures and systems.25 26 Leaders of multimillion dollar 
HRCS consortia, who are often primarily researchers, are 
expected to deal with these managerial complexities.25 The 
evidence base to support the navigation of this complex 
endeavour in the HRCS context is neither well defined nor 
sufficiently understood.27–29
There are indicators of increasing attention to consor-
tium management practices in HRCS initiatives. Examples 
include the requirement by some funding bodies for explic-
itly stated consortium management outputs in programme 
theories of change,30 and the development of consortium 
management tools such as the research fairness initiative31 
and guides for research partnerships.32 33 It is clear that 
consortium management is an integral part of the global 
HRCS effort, and a robust evidence base including under-
standing consortium management processes and practices 
and their effectiveness is essential. This review aims to 
ascertain the breadth, depth and quality of the published 
evidence on HRCS consortium management, and identify 
the management processes, experiences and key issues 
raised by consortium actors, and the knowledge gaps in the 
available evidence.
MeTHods
Type of review
Due to the paucity of robust HRCS research publica-
tions,34 conducting a standardised systematic review 
which requires high-quality research evidence35 36 was 
not feasible. We thus conducted a systematised review, 
which models the systematic review process without strict 
adherence to study inclusion criteria.35 We aimed to 
be widely inclusive to draw out the full range of HRCS 
consortium management-related data in the published 
literature, necessitating the inclusion of all types of 
peer-reviewed literature without limitation to publication 
type (research based or not) and quality.
data sources, search strategy and selection of papers
A systematic electronic search of peer-reviewed arti-
cles using PubMed and Scopus was conducted without 
any date restrictions. The search was limited to peer-re-
viewed literature as the aim of this review is to identify 
the extent of and findings from existing scientific litera-
ture pertaining to HRCS consortium management. The 
search terms used were (1) health AND (2) research AND 
(3) capacity AND (4) strengthening AND (5) consortium 
AND (6) LMICs, together with variants of some of the 
terms (online supplementary table S1). LMIC is defined 
according to the current World Bank classifications.37 
Four geographical regions with the highest concentra-
tion of LMICs namely Africa, Asia, Latin America and 
the Caribbean, and Pacific were included to optimise the 
search. Results were saved in an Endnote X8 library.
Identified papers were first screened by the first author 
against the inclusion criteria using titles and abstract. 
An article was included if it (1) focused on one or more 
consortium-based HRCS initiatives; (2) involved LMICs 
and (3) included descriptions, processes, findings or 
reflections related to the establishment and ongoing 
management of consortia. Additional criteria were 
papers published up to December 2018 with both abstract 
and full paper available in English. The restriction to 
include only papers written in English was due to lack 
of resources for translation and time limitations. Articles 
were retained for full-text review if they met the criteria or 
more information was required to decide, after which the 
final selection was made. There was an agreed process for 
team consultations when it was unclear whether or not to 
include a paper. Additional papers were identified by a 
manual search which included checking the references 
and supplementary lists of identified articles and citation 
searching.38
Quality appraisal
Though there was no quality threshold for inclusion, an 
appraisal of the selected articles was carried out to give 
an indication of the quality of the current evidence on 
HRCS consortium management. The Mixed Methods 
Appraisal Tool (MMAT) was used due to its suitability for 
appraising multiple design studies.39 The tool includes 
screening questions which assess the eligibility of papers 
for full appraisal. It comprises sets of criteria for qual-
itative, quantitative and mixed studies, and metrics for 
determining the overall quality score for each study.40 
The empirical papers were screened and the qualifying 
papers assessed for methodological quality and scored. 
A second reviewer conducted an independent appraisal 
of all the papers. An initial discussion between the two 
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reviewers was held in advance to ensure a common 
understanding of the tool. A third reviewer facilitated the 
resolution of any divergences.
data extraction and analysis
Data were extracted from the selected papers using the 
matrix method.41 This method provides a structured way 
of recording extracted information and findings from 
each publication using a table, facilitating a systematic 
synthesis process. Columns representing specific areas of 
interest were used to capture data. These included the 
following: publication authors and year; characteristics 
of the HRCS programme such as goals, main activities 
and geographical focus; and consortium characteristics 
such as structure, size and composition. Study objectives 
and design, methods used in data collection, sampling 
and analysis, and frameworks or guidelines applied were 
also obtained from empirical papers. Findings from 
each paper were categorised into three broad areas: 
(1) descriptions of management processes and systems 
adopted during the consortium’s formation and imple-
mentation, (2) experiences and lessons learnt and (3) 
effect of the processes and experiences on the achieve-
ment of programme goals. A thematic synthesis of the 
extracted data was then carried out which involved induc-
tively identifying any descriptive and analytical themes, 
as well as similarities, divergences and associations across 
papers. To strengthen the rigour of the process, each 
step and output was independently assessed by a second 
reviewer.
resulTs
study selection
The electronic search yielded 5378 papers of which 1325 
duplicates were removed, retaining 4053 (figure 1). In 
all, 3772 articles were rejected based on a review of the 
title and abstract, and an additional four were excluded 
as the full texts were not accessible for three and the 
fourth was not available in English. Of the 277 potentially 
relevant articles, 46 were retained after a full-text review, 
and a manual search identified nine additional articles, 
resulting in 55 included papers made up of 18 empir-
ical papers and 37 commentaries (table 1). A detailed 
summary of the papers is presented in online supplemen-
tary table S2 and S3.
Characteristics of included papers
Only one paper was published before 2000, with the 
majority (47 out of 55) published between 2010 and 
2017, indicating a sixfold increase compared with the 
period preceding 2010 (figure 2). The highest number 
of papers published in a year was eight. Half of the 
papers (n=28) had neither the first nor last authors affil-
iated to LMIC institutions, and in a fifth, there were no 
LMIC-affiliated authors at all (table 1). Last authors (48 
out of 55) were primarily affiliated to high- and upper 
middle-income countries.
There were twice as many commentaries as empirical 
research papers (table 1), with 14/18 empirical papers 
based on qualitative studies and four on mixed methods. 
Almost all empirical papers (n=17) had a learning and 
evaluation focus, 10 of which were conducted internally 
and the rest by external assessors. Only seven qualitative 
papers were scored in the top half of the MMAT quality 
range (online supplementary table S2) based on having 
clear research objectives, using data sources and analysis 
approaches relevant for addressing the research ques-
tions, and giving appropriate consideration to how the 
findings relate to the context while the other qualitative 
research papers presented very little data on these. The 
remaining papers had used mixed-method approaches 
without clearly indicating the rationale or data integra-
tion process or adhering to sampling and other quantita-
tive methodological criteria.40
Included papers sought to evaluate or reflect on the 
consortium’s operations particularly on the activities and 
outputs, with only a third primarily focusing on the part-
nership experience, assessing the successes, challenges 
and lessons learnt from the perspective of consortium 
actors. Evaluation of consortium management processes 
was the sole or prominent aim of only two papers,42 43 
one of which happened to be the only paper reporting a 
failed consortium.
description of consortia
The 55 identified papers represented 51 distinct HRCS 
programmes, as three programmes were reported in 
several publications. There was an inconsistent use of 
terms in describing the collaborative set-ups, with 39 
papers using two or more terms interchangeably, and 
one paper using five. The most commonly used terms 
were partnership (n=22), network (n=11) and consor-
tium (n=10), and fewer uses of collaboration (n=4), 
alliance (n=2) and community of practice (n=2). Only 
five papers provided definitions of the used terms, which 
varied considerably.44–48
The 51 consortia varied widely in size, ranging from 
2 to 20 institutional partners. The HRCS programmes 
included LMICs, mostly in Africa (n=38). Of the 41 
consortia that had reported on leadership, 32 were led 
by high-income country partners (table 1). As shown 
in table 1, HRCS was either the primary focus of the 
programmes or a component of a broader research, 
educational or clinical care programme. Consortia 
sought to build capacity using a single or combination 
of activities, mostly training of individuals (short term 
and degree awarding) and learning ‘on the job’ through 
conducting collaborative research. None of the papers 
indicated the process used or factors that determined the 
selection of HRCS activities.
operational aspects of consortium management
A range of management structures and processes 
adopted by consortia during their inception and imple-
mentation phases were reported across papers. These 
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Figure 1 Paper screening and selection process.
included partner selection and partnership development 
during the inception phase, and management structures, 
coordination, and monitoring during the implementa-
tion phase. These were neither the primary focus of the 
publications nor examined in detail, but rather brief 
descriptions introducing or providing context for studies 
and reflections. Below, we present data on operational 
processes used in the HRCS inception and implementa-
tion phases as well as data on relational aspects of consor-
tium functioning (table 2).
Inception processes
Most consortia were formed in response to an HRCS 
funding opportunity and were initiated by the primary 
grant holder or principal applicant. There was one 
exception, where formation was the initiative of a govern-
ment representative from the LMIC.49 Criteria for partner 
selection were discussed in 22 papers (figure 3), with the 
most cited criteria being previous individual and insti-
tutional working relationships (n=17), and expertise or 
experience in the disease or research area (n=9). Many 
papers (n=11) reported considering two or more criteria. 
It was not indicated in any paper if there were any consid-
erations for determining the number or type of partners.
In 11 cases, consortia reported engaging in a partner-
ship development process also referred to as an ‘engage-
ment phase’,50 ‘inception phase’42 51 or ‘establishment 
process’.52 Typically, this process was used to facilitate 
partner and stakeholder engagement, identify partner 
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Table 1 Summary of publication and programme 
characteristics
Category Characteristic Description
No. and 
percentage 
of 
publications
Publication 
characteristics 
(N=55)
Type of 
publication
Empirical 
research
18 (33%)
Commentary 37 (67%)
  First author 
affiliation
HIC 36 (66%)
U-MIC 4 (7%)
L-MIC 6 (11%)
LIC 9 (16%)
  Last author 
affiliation
HIC 38 (69%)
U-MIC 10 (18%)
L-MIC 3 (6%)
LIC 4 (7%)
Programme/ 
consortium 
characteristics
(N=51)
Geographical 
focus*
Africa 37 (73%)
Asia 12 (24%)
Latin America 
and the 
Caribbean
7 (14%)
Pacific 1 (2%)
  Consortium 
leadership
HIC 32 (63%)
  U-MIC 2 (4%)
  L-MIC 3 (6%)
  LIC 2 (4%)
  Led by both 
L-MIC and LIC 
partners
2 (4%)
  Not indicated 10 (19%)
  Capacity 
strengthening 
focus
Dedicated RCS 
initiatives
23 (45%)
  Embedded RCS 
initiatives
28 (55%)
  Subject focus
  
Disease or 
discipline focus
38 (74%)
  Generic 11 (22%)
  Not indicated 2 (4%)
  Main activities* Training 
individuals
40 (78%)
  Collaborative 
research
25 (49%)
  Institutional 
capacity 
enhancement
11 (22%)
  Developing 
collaborations
9 (18%)
  Knowledge 
translation
9 (18%)
  Infrastructure 
enhancement
4 (8%)
*Some programmes combined two or more categories.
HIC, high-income country; LIC, low-income country; L-MIC, lower 
middle-income country; RCS, research capacity strengthening; 
U-MIC, upper middle-income country.
needs and expectations, determine consortium goals, 
assign roles, establish governance structures, consortium 
guidelines and procedures, and develop a plan of action. 
This phase or process was reported to promote open-
ness, trust and build team work,52 as well as help partners 
acknowledge and deal with any assumptions held.53 Only 
three papers51 54 55 described the use of a framework or 
tool to guide this process, citing the Partnership Assess-
ment Tool, the four-dimensional Appreciative Inquiry 
Framework and the International Participatory Research 
Framework, respectively.
Implementation processes
The governance structures adopted by consortia were 
reported in a third of the papers. Governing bodies were 
similar across consortia and generally fell into four cate-
gories: advisory bodies that provided strategic advice,56–58 
steering committees that made strategic and opera-
tional decisions,43 58 59 executive teams responsible for 
the day-to-day management58 60 61 and implementation 
teams that executed consortium activities.57 62 63 These 
governing bodies were often made up of representa-
tives from partner institutions. However, neither the 
factors informing the choice of management structure 
nor the effectiveness of the structures were discussed 
in any paper. One paper reported considering gender 
balance,59 and three described the involvement of junior 
researchers (in one case stating the capacity strength-
ening intent of the decision).25 62 64 The leaders of the 
consortia tended to be those who initiated the collabo-
ration, had the required resources or were selected to 
fulfil funder requirements.46 56 65 Researchers frequently 
took the lead management role in consortia. The role 
of a project manager or coordinator was reported in 
only two cases.58 60 One consortium employed trainees 
in management and administrative roles, and though 
this resulted in managerial capacity, it adversely affected 
their training progress due to the additional respon-
sibilities.42 The consortium management capacities 
of leaders and managers were neither mentioned nor 
discussed, although two papers pointed out the value 
of both management and technical expertise in leading 
consortia.25 49
In all, 21 papers mentioned activity coordination 
processes, and 22 indicated the incorporation of moni-
toring and evaluation elements. The most cited platforms 
for coordinating activities and monitoring progress 
were consortium meetings, management meetings and 
partner visits, as well as telephone and electronic commu-
nication. Factors reported to foster coordination and 
monitoring included regular communication, jointly 
determined goals and processes, previous working rela-
tionships, and the use of codes of conduct and guide-
lines.60 66 67 Lack of clarity about roles and guidelines,43 50 
and difficulties in organising meetings due to physical 
distances, time differences, conflicting partner priorities, 
and poor internet connectivity were reported as barriers 
particularly in large-sized consortia.60 68 69 Most of the 18 
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Figure 2 Number and type of publications per year. HRCS, health research capacity strengthening.
Table 2 Summary of management issues raised across 
papers
Category Description
No. of 
publications 
(%) (N=55)
Operational 
elements of 
management
  
  
  
  
Partner selection criteria 22 (40%)
Determinants of 
consortium leaders
8 (17%)
Partnership development 
phase
11 (20%)
Types of collaborative 
agreement used
7 (13%)
Governance structures 19 (35%)
Coordination of consortia 
activities
21 (38%)
Monitoring and evaluation 
of consortia activities
22 (40%)
Relational 
elements of 
management
Relationship building 45 (81%)
Equity and power 24 (44%)
Role of leadership 20 (36%)
Partner inclusion 16 (29%)
evaluations reported, whether internally or externally 
conducted, were programmatic in nature, focused on 
assessing training and research outputs, with only six 
reporting on partner relations and partnership successes 
and challenges. Frameworks used to guide these evalua-
tions were reported in six cases. These included the Swiss 
Commission for Research Partnerships with Developing 
Countries’ Guide for Transboundary Research Partner-
ships,19 65 Mercer et al’s70 Guidelines for Assessing Partici-
patory Research Projects,50 the Capacity WORKS Model,43 
Kernaghan’s types of partnerships48 and the realist meth-
odology approach.49 These frameworks are orientated 
towards examining research partnerships more broadly, 
with only the Capacity WORKS model71 tailored specifi-
cally to capacity development programmes.
relational aspects of consortium management
The four critical factors identified from the range of 
successes, challenges, enablers, barriers and lessons 
learnt shared across papers were relational in nature 
specifically building partner relationships, equity and 
power, leadership and inclusion. Although interrelated, 
we present the data shared on these key factors in turn, 
returning to the potential interplays in the discussion.
Partner relationships
The most discussed factor reported as influencing consor-
tium success was the importance of fostering strong rela-
tionships between partners, with nearly all papers (n=45) 
commenting on this. The value of informal networks and 
friendships among individual partners in consortium 
success was emphasised.26 42 43 69 72 In addition to their 
influence on the achievement of programme delivera-
bles and consortium sustainability, effective relationships 
were in themselves seen as capacity outcomes.26 45 60 62
While these [courses and workshops] were the quantifiable 
outputs…, much of the experiences in capacity building 
are not measurable: these may focus on relationship dy-
namics, work and the learning experienced by the partici-
pants involved (p. 4)60
Many participants reported that new relationships devel-
oped during the project implementation were the most 
important outcomes (p. 5)60
Partner relationships were fostered by principles such 
as openness, trust, mutual respect, transparency, shared 
commitment and recognition42 66 73 74; and practices 
such as establishing guiding principles and norms, joint 
planning and implementation processes and regular 
communication.49 59 The importance of recognising and 
leveraging on differences in partner needs, strengths, 
interests, objectives, expectations, contexts and culture 
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Figure 3 Partner selection criteria used and the number of publications that mention criteria.
to nurture effective relationships was also noted.49 74–76 
Almost half of the papers (n=21) reported encountering 
challenges when partner differences were not acknowl-
edged and monitored.26 29 49 68 73–76 At the same time, the 
investment required (in time and other resources) and 
practical challenges of building relationships were recog-
nised, particularly when partners were spread across 
continents.29 42 50 63 69 77 78 As demonstrated in one study, 
participants ‘found the process of establishing relation-
ships and reaching consensus… laborious and at times 
negotiation-intensive’ (p. 4).63 One consortium shared 
their learning:
All collaborators should be aware of the fluid and the ini-
tially challenging processes that are normal for group de-
velopment. Partners should allow sufficient time for com-
plex and consultative decision making (p. 15)42
Inequity and power imbalances
In all, 24 papers discussed inequity and power imbal-
ances among partners, most often in terms of the ineq-
uitable division of resources, control and benefits. These 
were noted to have stemmed from pre-existing asym-
metries between partners, as well as consortium design 
factors.77 78 Pre-existing asymmetries were reported to be 
based on differences in partners’ resources, income levels 
and expertise, with differences between North and South 
partners most often noted. These asymmetries predis-
posed consortia to power imbalances, exacerbated by 
consortium arrangements for access to funding, resource 
allocation and leadership.77 78 ‘Lopsided’ arrangements 
were reported to result in more-resourced partners taking 
up more conceptual roles and being perceived as capacity 
providers, and less-resourced partners becoming imple-
menters and capacity receivers.51 73 78–80 Thus, unequal 
power relations are entrenched, and the ability of less-re-
sourced partners to negotiate better terms undermined.
When the Northern partner serves as the primary grant 
recipient (and the Southern partner is subcontracted) a 
level of inequality is created that is difficult to overcome, 
no matter what provisions are made to make decisions eq-
uitably (p. 4)77
…it is too often assumed that the more developed nation 
has more to offer. This erroneous perspective is a fatal flaw 
in the development and progress of such collaborative ef-
forts and is usually accountable for a number of failed at-
tempts at collaboration due to its skewed balance of power 
(p. 101)81
“partners with less funding (almost entirely LMIC part-
ners) confirmed that they felt as though they had less influ-
ence in decisions (p. 7)60
Power imbalances were not limited to North-South 
collaborations, but also encountered between ‘bigger’ 
and ‘smaller’ Southern partners.48 68 78 Openly acknowl-
edging and discussing these issues were described 
as important in addressing this challenge in several 
papers26 42 45 51 53:
There are interests at stake among Southern universities 
just as there are among Northern universities… therefore 
power and interest dynamics are at play in South-South 
partnerships just as they are in North-South and North-
North partnerships (p. 146)
Without honest exchange, and an acknowledgment of the 
differential power at work in seeking to resolve tensions in 
perspective, the notion of ‘equitable partnership’ was seen 
as illusory (p .4)26
Others recommended negotiating and instituting 
consortium agreements and structures that promote 
power-sharing and equal division of resources, deci-
sion-making capacity and benefits,19 63 77 81 82 noting that 
these are not guarantees and sustained partner commit-
ment to equal partnerships, mutual respect, trust, and 
reciprocity are still required.48 50 52 55 73 77
Lack of inclusion
Lack of inclusion of all partners especially during the 
early stages was raised as a concern, particularly of 
Southern consortium actors. In a Bangladesh–British 
partnership for instance, the project proposal was 
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primarily developed by the Northern partner, resulting 
in implementation difficulties.79 Another author noted 
the following:
Many participants described their partnership experiences 
as more 'incorporation' than 'collaboration', having been 
provided little to no opportunity to participate in priori-
ty-setting or in leadership roles (p. 142)51
It was interesting to note that even in an LMIC-led 
consortium, decisions regarding a component being led 
by the high-income country partners were described as 
‘top-down’ leading to some tension within the partner-
ship.42 Across several papers, partner inclusion in all 
consortium processes, particularly in decision-making, was 
reported to engender ownership and commitment across 
both internal and external stakeholders.10 52 63 81 Inclu-
sion of wider institutional actors, and being cognisant of 
host institutional leadership and structures when deter-
mining and executing consortium processes, was consid-
ered critical to HRCS success.59 60 In one consortium, the 
involvement of a wide range of stakeholders in concep-
tualising the HRCS project was seen to contribute to a 
‘truly cooperative partnership based on trust and mutual 
respect’,73 while in others the lack of alignment with insti-
tutional agendas was considered detrimental.43 60
Leadership
Leadership was identified as a key attribute of successful 
consortium management in over a third of papers. It was 
deemed a major determinant of consortium success or 
failure,49 83 and its pivotal role was also demonstrated 
when some consortia faced leadership changes.43 60 77 As 
noted by an author,
A successful partnership requires strong leadership to 
make decisions, take appropriate risks, and solve problems 
(p. 6)84
In addition to providing direction and overseeing 
performance, vital aspects of leadership identified 
included demonstrating diplomacy and ensuring that 
partners are engaged throughout the consortium’s life-
cycle.45 62 63 In one consortium, leaders’ commitment 
to inclusive partnership was considered instrumental in 
overcoming initial reservations of less-resourced partners 
in joining the consortium at all.80
effect of management processes and experiences on 
outcomes
Linkages between consortium management processes 
and programme outcomes were not clearly articulated, 
and only alluded to in a few recommendations made. 
Linkages made included observations that programme 
designs focusing on a wide range of human and infra-
structural capacities25 85 86 across micro-, meso- and 
macro-levels49 73 77 87 produce more synergistic interac-
tions and sustainable capacity. Acknowledging existing 
capacities of all partners and according mutual respect 
were noted to promote multidirectional capacity 
transfer,29 49 81 88 and correspondingly tailoring partners’ 
participation resulted in more contextually relevant 
and sustainable outcomes.42 76 82 83 The significance of 
consortium management in achieving research capacity 
strengthening outcomes is increasingly being acknowl-
edged.25 59 73 Efficient management was named as one of 
four outputs in one consortium’s programme theory of 
change.42 Another paper identified the lack of manage-
ment skills as a risk factor for consortia, criticising the 
reliance on the ‘learning-by-doing’ means of acquiring 
those skills which tends to happen late in consortia 
leaders’ careers.82 Some recognition of a more central 
capacity strengthening role of management activities was 
demonstrated in a few cases where partner interactions 
at both management and implementation levels were 
noted to generate exchange of knowledge and skills,69 
and provide opportunities for mentoring and ‘behaviour 
modelling’.73 On the significance of these processes, one 
author pointed out:
What these [process] evaluation reports invariably facil-
itated was increased awareness of how underlying, often 
ignored or taken-for-granted processes influence project 
work and outcomes (p. 141)25
dIsCussIon
To the authors’ knowledge, no previous reviews have 
been conducted to ascertain the state of the evidence 
base for HRCS consortium management. This review 
seeks to provide a first step in assessing the consortium 
management publication landscape specifically in the 
HRCS domain and to draw attention to the need for 
purposeful HRCS-specific management science. We 
note that findings presented may not represent the 
entirety of HRCS consortia experiences. All but one 
paper reported successful collaborations, and discordant 
leader or partner perspectives were only reported in one 
case, indicating the possibility of publication and social 
desirability biases, respectively. Indeed, one participant 
disclosed their consortium’s deliberate decision not to 
report their ‘dirty laundry’ in a peer-reviewed publica-
tion.48 Thus, experiences of unsuccessful consortia may 
exist but are unpublished, and authors and study partici-
pants of selected papers may have been cautious in their 
publications and responses to avoid potential tensions 
and maintain relationships. Data from unpublished work 
or those published outside of peer-reviewed journals, or 
in languages other than English, or indexed in other 
databases, would have been excluded from this review. 
However, we used a systematic approach in carrying out 
the review ensuring a high level of rigour, and integrated 
diverse types of published literature to widen the range of 
included viewpoints.
The review indicates an increase in attention being 
given to HRCS consortium management-related issues 
in recent years. Yet, yearly publication outputs remain 
low, and the available evidence is weak both in terms of 
quantity and quality. Consortium management was not a 
clearly defined focus for most papers, and there was little 
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coherence in its assessment across papers. The absence 
of LMIC authors in a significant proportion of publica-
tions also raises questions about the level of meaningful 
LMIC involvement and leadership in the LMIC-focused 
HRCS consortium management literature. Possible 
contributors to this authorship pattern include the domi-
nance of high-income partners in consortium leadership, 
and broader structural and contextual factors which 
contribute to this imbalance such as resource and exper-
tise constraints. Of note is that the nascent nature of the 
management-specific evidence reflects a similar trend in 
the broader HRCS literature, except that there is a better 
representation of LMIC authors in the latter.34 These 
imbalances and the factors contributing to them need to 
be addressed, with a particular emphasis on correcting 
the under-representation of LMIC perspectives in the 
available evidence.
Across the available evidence base, terms used for collab-
orations such as partnership, network and consortium 
are used inconsistently and interchangeably, a point also 
noted by others.59 89 Similarly, the concept of ‘(health) 
research capacity strengthening’ has been inconsistently 
applied across the broader HRCS literature.34 Thus, 
it is not entirely clear how an HRCS consortium might 
differ from a traditional health research consortium or 
how a consortium might differ from a partnership or 
network. Although not discussed in the literature, the 
lack of standard definitions and delineation of terminol-
ogies could lead to challenges with multiple perceptions 
of the nature and practices of a collaboration, as well as 
different partner expectations. Concerns about clarity 
in the use of terms contributed to efforts by Edwards et 
al89 to develop a typology of international health partner-
ships to facilitate evaluations by positing a classification 
according to the level of impact (individual or organi-
sational), capacity strengthening approach and the type 
of relationship between partners. Beyond ensuring the 
use of appropriate comparators in evaluation,89 charac-
terising collaborations and being explicit about the attri-
butes of the collaboration and degree of involvement, 
for instance, should promote consonance in partner 
thinking, approaches and expectations.
Our findings indicate greater emphasis on the rela-
tional aspects of management in the reviewed literature 
than on operational factors. Relational aspects such as 
relationship building, equity, power relations and lead-
ership were identified as having the most influence 
on and requiring the greatest attention for successful 
HRCS consortium management. Though extensively 
mentioned, these elements were inadequately interro-
gated. It would be valuable to examine in more depth, 
for example, the different approaches to leadership (in 
theory and practice) and the sources and influences 
of power and power relations in the context of HRCS 
consortia. Operational aspects of management such as 
establishment processes, and governance structures and 
procedures, were given less attention. Given that rela-
tional and operational aspects of collaborations have 
been identified as interdependent elements of consor-
tium management,45 90 91 it is unclear why the operational 
aspects are relatively neglected, and the interdependency 
and interplay between the two largely ignored. Only three 
papers hinted at any linkages.45 77 78 For example, Van der 
Veken et al78 pointed out that inequity and power imbal-
ances are as determined by consortium structures as they 
are by pre-existing contextual factors, and Vasquez et al77 
noted that formalised consortium structures are not suffi-
cient in themselves in addressing power differentials and 
ensuring equity without commitment to the appropriate 
principles.
The lack of correlation between relational and opera-
tional elements in the literature is further evidenced in 
the linear nature of the partnership frameworks applied 
in the reviewed papers which rarely elicited the relational 
complexities inherent in consortium processes. Indeed, 
the importance of this interdependency is also recognised 
in business partnerships where emphasis is placed on 
going beyond formal governance structures to fostering 
collaborative relationships and behaviour.92 93 There is a 
growing recognition of the significance of this interplay 
in the health systems context where the need to equally 
pay attention to strengthening organisational hardware 
such as finances and technology, tangible software such 
as systems and procedures, and intangible software such 
as relationships and power has been emphasised.94 95 
Thus, in future research, it will be worth examining how 
the relational and operational aspects enhance or hinder 
each other, and a first step will be to unpack and examine 
both the conceptual and practical content of each aspect 
particularly pertaining to the research capacity strength-
ening context. Exploring this interrelatedness will 
contribute to a more nuanced understanding of consor-
tium management and contribute to the development of 
more holistic frameworks for guiding consortium opera-
tions and management.
Very little association has been made between HRCS 
consortium processes and capacity outcomes in the liter-
ature. There was almost no discussion in the reviewed 
literature on the ‘position’ of management in the HRCS 
effort and whether it merely supports a capacity devel-
opment process or is a capacity development mecha-
nism or target in its own right. This gap may be a result 
of the prevalent focus on HRCS activity outputs such as 
individuals trained and research conducted which are 
widely used as proxies for capacity,96 and the apparent 
prioritisation of technical research skills over managerial 
expertise. Though HRCS activities focus more on tech-
nical research tasks than non-technical relational skills, 
the emphasis in the HRCS consortium management 
literature is on the latter. This could be an indication 
that consortium processes may be segregated from the 
capacity strengthening process and only perceived as a 
means to an end. Though there is a growing recogni-
tion of the role of management in HRCS consortia, its 
handling in the available published literature is rudimen-
tary. Even where management is explicitly named as an 
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output, the focus remains on programme efficiency with 
management a facilitator of other programmatic outputs 
rather than a valuable capacity building output in itself.42 
Besides, even programmes with explicit capacity strength-
ening strategies appear to be prioritising the ‘research’ 
over the ‘capacity’.9 In addition to ensuring HRCS 
programme models have ‘dedicated’ capacity strength-
ening foci,9 it is our view that the recognition and utilisa-
tion of management processes as capacity strengthening 
mechanisms in their own right are essential if research 
capacity goals are to be met. Considering the philosophy 
underpinning HRCS consortia,1 capacity development 
needs to permeate both processes and deliverables, and it 
is essential that both technical components and manage-
ment approaches and processes adopted contribute to 
the capacity strengthening outcomes. As demonstrated 
by the UK Department for International Development’s 
example of impelling the incorporation of consortium 
management into programme theories of change,30 
funders could play a key role in driving the prioritisa-
tion of consortium management and ensuring it receives 
adequate support (including funding) in its operation-
alisation and evaluation. This has been evidenced in the 
HRCS movement where funders such as the US National 
Institute of Health and the European Commission ensure 
that funding is committed to capacity building even in 
primarily research-oriented programmes.
ConClusIons
The consortium model has been widely adopted for 
strengthening health research capacity in LMICs. Yet, 
the evidence base to inform HRCS implementation is 
weak, and HRCS consortium actors lack the theoretical 
and empirical bases for framing their practice. From the 
limited evidence published to date, relational aspects of 
consortium management have been recognised as essen-
tial to HRCS programme success but not examined in 
depth. Operational processes have rarely been discussed, 
and it is unclear whether this is due to a lack of under-
standing or a lack of perceived importance. As a result, 
the interplay between operational and relational aspects 
of consortium management has not been well explored. 
The actual contribution of consortium management 
to HRCS outcomes is poorly documented, and the 
‘position’ of management within the broader capacity 
strengthening agenda remains unclear. Considering 
the growing investments in consortia implementing the 
LMIC-focused HRCS agenda, it is essential to advance a 
corresponding consortium management framework to 
underpin the effort.
The proliferation of HRCS consortia provides oppor-
tunities for further research towards broadening the 
evidence base. The gaps identified in the literature high-
light the need to pay more attention to both theoretical 
and empirical investigation of consortium management 
processes, influencing factors, and their role in attaining 
the capacity strengthening aims of consortia. Such 
research needs to aim for more conceptual depth, making 
use of robust study designs and adhering to research 
reporting requirements to overcome the quality prob-
lems identified. It is also essential to ensure definitional 
clarity and operational interpretation of key influencing 
factors such as equity, power and leadership particularly 
in the HRCS context, thus supporting appropriate trans-
lation into much-needed practical guidelines for funders 
and research practitioners. These may be useful initial 
steps in strengthening HRCS implementation science 
and boosting the evidence base needed for policy and 
practice.
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